Siegfried Holding AG
SFZN
Peringkat dalam Saham
#4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Harga Saham
$88.34
Kapitalisasi Pasar
$3.87B
Perubahan (1 hari)
1.68%
Perubahan (1 tahun)
-12.97%
Negara
CH
Perdagangan Siegfried Holding AG (SFZN)
Kategori
Healthcare
Jumlah saham beredar untuk Siegfried Holding AG (SFZN)
Jumlah saham beredar per October 2026: 0
Menurut laporan keuangan terbaru dan harga saham Siegfried Holding AG, jumlah saham beredar saat ini adalah 0. Pada akhir October 2026, perusahaan memiliki 0 saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Siegfried Holding AG (SFZN) dari 2002 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2025 | 43.76M | 1.54% |
| 2024 | 43.09M | 1.69% |
| 2023 | 42.38M | 0.40% |
| 2022 | 42.21M | 0.37% |
| 2021 | 42.05M | 1.45% |
| 2020 | 41.45M | 0.22% |
| 2019 | 41.36M | -0.67% |
| 2018 | 41.64M | 4.91% |
| 2017 | 39.69M | 2.15% |
| 2016 | 38.86M | -1.72% |
| 2015 | 39.54M | 2.20% |
| 2014 | 38.68M | -1.37% |
| 2013 | 39.22M | 8.27% |
| 2012 | 36.23M | -1.32% |
| 2011 | 36.71M | 8.64% |
| 2010 | 33.79M | 22.52% |
| 2009 | 27.58M | -0.49% |
| 2008 | 27.71M | 0.30% |
| 2007 | 27.63M | -0.21% |
| 2006 | 27.69M | 0.25% |
| 2005 | 27.62M | 1.23% |
| 2004 | 27.28M | 0.00% |
| 2003 | 27.28M | -0.13% |
| 2002 | 27.32M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
